04/29/2024
3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:10 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/22/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
10:21 AM | Intellia Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024
3:15 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | BlackRock Inc. (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024
3:44 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:46 PM | Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:49 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:51 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:28 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:34 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:35 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:09 PM | Crowley John F (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
8:30 AM | Intellia Therapeutics (Filer)
| Form S-3ASR | |
11/09/2023
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:42 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
6:11 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
6:19 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:13 PM | Intellia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
4:19 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
3:45 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
4:21 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:22 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023
2:34 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:52 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:39 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
06/16/2023
3:24 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:26 PM | Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:13 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
3:52 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:41 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
